Protagonist Therapeutics, Inc. (PTGX)
NASDAQ·Healthcare·Biotechnology
$110.72
+0.28%
Mkt Cap $6.81B
Analyst Ratings
Buy
12
Hold
1
Sell
0
Price Target (16 analysts)
$116.75
Range $108.00 – $121.00
Implied Upside
+5.5%
Consensus $116.75 vs current $110.72